ReviewBiotechnology for biofuels and bioproducts2025
Benchmarking commercially available value-added fractions with potential for production via microalgae-based biorefineries: is it worth it?
Review in Biotechnology for biofuels and bioproducts, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- An Overview of Bioproducts from Wastewater-Grown Microalgae: Recent Advancements, Economic and Feasibility Concerns.Microorganisms · 2026Review
- From Microalgal Biomass to Products: Downstream Processing Technology Gaps and the Road to Commercial Diversification.Microorganisms · 2026Review
- Current Trends, Future Prospects and Constraints of Whole Microalgae and Their Fractions as a Functional Feed Ingredient for Animals.Journal of animal physiology and animal nutrition · 2026Review
- Enhancement of growth and zeaxanthin accumulation via gene expression and metabolic pathways modulation in Chromochloris zofingiensis mutant CZ-Z12.Biotechnology for biofuels and bioproducts · 2026Article
- Innovative advances in microalgal high-value products: unlocking potential from bioprocessing to bioindustrial applications.Frontiers in bioengineering and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The urgent need to mitigate climate change requires finding sustainable and efficient alternatives to fossil fuel-based materials. Biosequestration by microalgae has been suggested as a potential method for climate change mitigation due to its environmentally friendly nature and ability to produce high-value compounds. However, the large-scale application of microalgal biorefineries faces significant challenges, particularly in the harvest and processing stages, which are often costly and energy-intensive. This study aims to benchmark value-added fractions that can be produced via microalgae-based biorefineries against their commercially available counterparts. A systematic review was conducted using the Web of Science™ database to identify current commercial sources of proteins, lipids, polyunsaturated fatty acids and pigments, this study identified key sectors and applications for each fraction, as well as potential market competitors. The results highlight substantial cost differences across production systems, with traditional agricultural sources demonstrating lower CAPEX but greater environmental challenges. Meanwhile, microalgal systems, although associated with higher CAPEX, offer advantages such as reduced land and water dependency, potentially leading to long-term economic resilience and environmental sustainability. By pinpointing research trends, key sectors and optimization opportunities, this work offers valuable insights into the profitability and competitiveness of microalgal systems, providing a benchmark for future optimization efforts. The novelty of this research lies in its comprehensive comparison of microalgae-based and traditional production systems, establishing a clear benchmark for microalgal production and suggesting focus areas for enhancement.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.